CartilaGen

CartilaGen is a startup focusing on developing drug-eluting bioactive materials to treat articular cartilage damage and osteoarthritis.

CartilaGen is a biotechnology startup focusing on developing drug-eluting bioactive materials to treat articular cartilage damage and osteoarthritis.

Number of Funding Rounds

Total Funding Amount

1

—

CartilaGen has raised a total of — in funding over 2 rounds. Their latest funding was raised on Feb 23, 2021 from a Grant round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Feb 23, 2021	Grant	—	1	Iowa G2M Accelerator	—	Detail

Number of Lead Investors

Number of Investors

1

CartilaGen is funded by 1 investors. Iowa G2M Accelerator are the most recent investors.

Investor Name	Lead Investor	Funding Round
Iowa G2M Accelerator	Yes	Grant